Female Hormone Profile
A six-marker hormone panel measuring oestradiol, progesterone, LH, FSH, testosterone, and SHBG.
Irregular periods — cycles that are consistently unpredictable, very short, very long, or absent — are almost always driven by an identifiable hormonal imbalance that a blood test can reveal.
Irregular periods — medically termed oligomenorrhoea (infrequent periods) or amenorrhoea (absent periods) — describe menstrual cycles that deviate significantly from the typical 21–35 day pattern. This includes cycles that are persistently shorter than 21 days, longer than 35 days, absent for more than three months, or highly variable from month to month. Irregular periods are not merely inconvenient — they signal disruption to the hormonal axis that governs ovulation, fertility, and long-term bone and cardiovascular health.
The most common cause of irregular periods in women of reproductive age is polycystic ovary syndrome (PCOS). PCOS is characterised by elevated LH relative to FSH, raised testosterone, and often insulin resistance — all of which prevent the regular follicular development and ovulation that drives a normal cycle. Thyroid disorders are the second most important category: both hypothyroidism and hyperthyroidism disrupt the HPG (hypothalamic-pituitary-gonadal) axis and alter the FSH and LH signals needed to trigger ovulation. A TSH test is therefore essential in any investigation of cycle irregularity.
In women approaching 40, rising FSH and declining oestradiol signal the onset of the perimenopausal transition — a natural process but one that benefits from hormonal clarity. Adrenal dysfunction and chronic stress affect the cycle by suppressing GnRH pulsatility, effectively telling the pituitary to reduce FSH and LH output. Iron deficiency worsens the impact of heavy menstrual bleeding, and elevated HbA1c from insulin resistance directly disrupts ovarian hormone production. Understanding which of these mechanisms is driving irregular periods is the foundation of effective management.
PCOS is the most common cause of irregular periods in women under 40 — accounting for up to 80% of cases of oligomenorrhoea in the reproductive years. However, thyroid dysfunction, hyperprolactinaemia, perimenopause, adrenal disorders, and significant weight change can all produce identical cycle disruption. A PCOS diagnosis should never be made on period irregularity alone — blood tests measuring LH, FSH, testosterone, TSH, and fasting insulin are essential to distinguish PCOS from other hormonal causes and to confirm the diagnosis.
Irregular periods rarely occur in isolation — associated symptoms help narrow down the underlying hormonal cause and guide testing.
Irregular periods arise from disruption to several distinct hormonal axes — identifying which is driving the irregularity determines the correct investigation and treatment approach.
These are the key blood markers that reveal the hormonal cause of irregular periods and guide clinical management.
Several diagnosable conditions present with irregular periods as a primary symptom — each has distinct biomarker patterns and treatment pathways.
A structured approach to hormone testing provides a clear biological explanation for irregular periods in most cases.
Reproductive hormone tests — LH, FSH, and oestradiol — are most informative when taken on days 2–5 of the menstrual cycle (early follicular phase). If your cycle is absent or unpredictable, testing can be done at any time with an explanatory note to your clinician. TSH and HbA1c can be tested at any point in the cycle.
LH, FSH, and testosterone combined with TSH covers the two most common diagnoses. In PCOS, expect LH:FSH ratio greater than 2:1 alongside elevated testosterone. In thyroid disorders, TSH will be abnormal with corresponding free T4 change. These patterns are distinct and direct very different management.
HbA1c and fasting glucose identify the insulin resistance present in 70–80% of women with PCOS. DHEA-S helps distinguish adrenal androgen excess from ovarian androgen excess — an important distinction for treatment planning. SHBG is often low in PCOS and amplifies the effect of elevated testosterone.
Ferritin should be measured in all women with irregular or heavy periods. Iron deficiency worsens fatigue and is common in women with PCOS who experience heavy breakthrough bleeding. Vitamin D deficiency is associated with worsened insulin resistance and should be included in a comprehensive screen.
Private blood tests analysed by UK-accredited laboratories.
A six-marker hormone panel measuring oestradiol, progesterone, LH, FSH, testosterone, and SHBG.
A targeted three-marker panel measuring prolactin, LH, and FSH to investigate pituitary function, irregular periods.
A five-marker menopause panel measuring FSH, LH, oestradiol, testosterone, and SHBG.
A specialist two-marker panel measuring IGF-1 (insulin-like growth factor 1) and IGFBP-3 as stable surrogate markers for growth hormone status.
A 20-marker comprehensive hormone and wellbeing panel covering sex hormones, adrenal markers, thyroid function, metabolic indicators.
A six-marker metabolic and hormone panel assessing fasting insulin, HbA1c, glucose, cortisol, DHEAS, and adiponectin.
Alongside targeted blood testing, several evidence-based lifestyle interventions support hormonal regularity and cycle restoration.
Most cycle irregularity can be investigated and managed systematically, but certain presentations require prompt medical assessment.
These can point to a more serious underlying cause and should not be ignored.
The most common causes of irregular periods are PCOS, hypothyroidism, hyperthyroidism, the perimenopausal transition, and adrenal dysfunction. In young women, PCOS is by far the most common — characterised by elevated LH, raised testosterone, and often insulin resistance. In women over 35, perimenopausal hormonal changes should also be considered. Iron deficiency and significant weight change can also disrupt cycle regularity.
Yes — both hypothyroidism and hyperthyroidism can disrupt the menstrual cycle. An underactive thyroid typically causes heavy, infrequent periods or oligomenorrhoea, while an overactive thyroid may shorten the cycle or cause periods to become very light or absent. TSH testing should be included in every investigation of cycle irregularity, as thyroid disorders are common, treatable, and frequently overlooked in this context.
Not always — some women with PCOS have regular cycles but still have the hormonal and metabolic features of the condition. Conversely, irregular periods can result from many causes other than PCOS. The diagnosis of PCOS requires at least two of three criteria: irregular or absent periods, clinical or biochemical evidence of elevated androgens (such as elevated testosterone), and polycystic ovarian morphology on ultrasound. Blood tests measuring LH, FSH, testosterone, and HbA1c are essential to characterise the condition.
Yes — psychological and physical stress elevates cortisol, which inhibits the GnRH pulse generator in the hypothalamus. This reduces pituitary output of LH and FSH, preventing follicular development and ovulation. The result is delayed, irregular, or absent periods. Very low body weight and excessive exercise have an equivalent effect. A morning cortisol blood test can confirm whether adrenal-driven stress suppression is disrupting your cycle.
A comprehensive investigation should include LH, FSH, and oestradiol (ideally on day 2–5 of the cycle), total testosterone, DHEA-S, TSH, HbA1c, and ferritin. SHBG is a valuable addition as it reflects the biological activity of testosterone and is frequently low in PCOS. Trupoint’s female hormone profile and PCOS hormone screen cover all of these markers in a single private blood test.
This page is for general information only and does not replace personalised medical advice. If you are worried about your health, please speak to a qualified healthcare professional. Trupoint Health blood tests are analysed by UK-accredited laboratories.
Private blood tests analysed by UK-accredited laboratories, with clear results and optional GP review.